GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

AI reasoning does not necessarily require spending huge amounts on frontier models. Instead, smaller models can yield ...

A new testing framework designed to evaluate AI's chemistry skills has revealed gaps in what today's most powerful models can ...

OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...

Trey Paul was a CNET senior editor covering broadband. His 20+ years of experience as a writer and editor include time at the broadband marketplace Allconnect, as well as working with clients like ...

In this episode of eSpeaks, Jennifer Margles, Director of Product Management at BMC Software, discusses the transition from traditional job scheduling to the era of the autonomous enterprise. eSpeaks’ ...

The release of DeepSeek's low-cost models DeepSeek-V3 and R1 triggered a global tech stock selloff ‌last year, causing investors to question whether U.S. AI firms needed to spend billions of dollars ...

For over a decade, confusion over the size of the proton has held scientists back. Disagreeing measurements of the subatomic particle’s radius meant that scientists couldn’t test one of their key ...

Large-language models (LLMs) have taken the world by storm, but they’re only one type of underlying AI model. An under-the-radar company, Fundamental, is set to bring a new type of enterprise AI model ...

Share on Pinterest Recent research is highlighting different approaches that may better predict diabetes risk than current methods. Image credit: Narumon Bowonkitwanchai/Getty Images About every 1 in ...